Cargando…
Development of Primary Monolayer Cell Model and Organotypic Model of Uterine Leiomyoma
Cellular technologies are one of the most promising areas of biomedicine, which is based on the isolation of cells of various types, followed by their cultivation and use, or the use of their metabolic products, for medical purposes. Today, a significant part of biomedical research is carried out in...
Autores principales: | Shved, Natalia, Egorova, Anna, Osinovskaya, Natalia, Kiselev, Anton |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875914/ https://www.ncbi.nlm.nih.gov/pubmed/35200532 http://dx.doi.org/10.3390/mps5010016 |
Ejemplares similares
-
Development of iRGD-Modified Peptide Carriers for Suicide Gene Therapy of Uterine Leiomyoma
por: Egorova, Anna, et al.
Publicado: (2021) -
Organotypic culture as a research and preclinical model to study uterine leiomyomas
por: Salas, Ana, et al.
Publicado: (2020) -
Cytogenomic Profile of Uterine Leiomyoma: In Vivo vs. In Vitro Comparison
por: Koltsova, Alla S., et al.
Publicado: (2021) -
Polycondensed Peptide Carriers Modified with Cyclic RGD Ligand for Targeted Suicide Gene Delivery to Uterine Fibroid Cells
por: Egorova, Anna, et al.
Publicado: (2022) -
Peptide-Based Nanoparticles for αvβ3 Integrin-Targeted DNA Delivery to Cancer and Uterine Leiomyoma Cells
por: Egorova, Anna, et al.
Publicado: (2022)